Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Sarah Walker

Showing results (41-50 of 388) with videos related to

Pageof 39
Sort By:
Drugs|December 9, 2017
Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-AnalysisPaola Pansa, Yingfen Hsia, Julia Bielicki, et al.
Statistics in Medicine|February 3, 2023
The Personalised Randomized Controlled Trial: Evaluation of a new trial designKim May Lee, Rebecca M Turner, Guy E Thwaites, et al.
Clinical Trials (London, England)|October 31, 2023
When should factorial designs be used for late-phase randomised controlled trials?Ian R White, Alexander J Szubert, Babak Choodari-Oskooei, et al.
The Journal of Infection|July 15, 2022
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levelsQingze Gu, Nicola Jones, Philip Drennan, et al.
The ISME Journal|March 17, 2019
Modelling microbiome recovery after antibiotics using a stability landscape frameworkLiam P Shaw, Hassan Bassam, Chris P Barnes, et al.
Lancet (London, England)|October 25, 2003
Determinants of survival following HIV-1 seroconversion after the introduction of HAARTKholoud Porter, Abdel Babiker, Krishnan Bhaskaran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconvertersAbdel Babiker, Janet Darbyshire, Patrizio Pezzotti, et al.
Journal of Clinical Epidemiology|October 1, 2020
Combining Charlson and Elixhauser scores with varying lookback predicated mortality better than using individual scoresEmma Pritchard, Nicola Fawcett, T Phuong Quan, et al.
Microbial Genomics|June 20, 2020
Evaluation of methods for detecting human reads in microbial sequencing datasetsStephen J Bush, Thomas R Connor, Tim E A Peto, et al.
BMJ (Clinical Research Ed.)|November 22, 2008
Fairness of financial penalties to improve control of Clostridium difficileA Sarah Walker, David Spiegelhalter, Derrick W Crook, et al.
Pageof 39

Showing results (41-50 of 388) with videos related to

Sort By:
Pageof 39
Drugs|December 9, 2017
Evaluating Safety Reporting in Paediatric Antibiotic Trials, 2000-2016: A Systematic Review and Meta-AnalysisPaola Pansa, Yingfen Hsia, Julia Bielicki, et al.
Statistics in Medicine|February 3, 2023
The Personalised Randomized Controlled Trial: Evaluation of a new trial designKim May Lee, Rebecca M Turner, Guy E Thwaites, et al.
Clinical Trials (London, England)|October 31, 2023
When should factorial designs be used for late-phase randomised controlled trials?Ian R White, Alexander J Szubert, Babak Choodari-Oskooei, et al.
The Journal of Infection|July 15, 2022
Assessment of an institutional guideline for vancomycin dosing and identification of predictive factors associated with dose and drug trough levelsQingze Gu, Nicola Jones, Philip Drennan, et al.
The ISME Journal|March 17, 2019
Modelling microbiome recovery after antibiotics using a stability landscape frameworkLiam P Shaw, Hassan Bassam, Chris P Barnes, et al.
Lancet (London, England)|October 25, 2003
Determinants of survival following HIV-1 seroconversion after the introduction of HAARTKholoud Porter, Abdel Babiker, Krishnan Bhaskaran, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 11, 2003
Short-term CD4 cell response after highly active antiretroviral therapy initiated at different times from seroconversion in 1,500 seroconvertersAbdel Babiker, Janet Darbyshire, Patrizio Pezzotti, et al.
Journal of Clinical Epidemiology|October 1, 2020
Combining Charlson and Elixhauser scores with varying lookback predicated mortality better than using individual scoresEmma Pritchard, Nicola Fawcett, T Phuong Quan, et al.
Microbial Genomics|June 20, 2020
Evaluation of methods for detecting human reads in microbial sequencing datasetsStephen J Bush, Thomas R Connor, Tim E A Peto, et al.
BMJ (Clinical Research Ed.)|November 22, 2008
Fairness of financial penalties to improve control of Clostridium difficileA Sarah Walker, David Spiegelhalter, Derrick W Crook, et al.
Pageof 39